LifeStance Health Group I... (LFST)
LifeStance Health Group Inc. (LFST) Stock Price, Analysis & Data
| Bid | 8.34 |
| Market Cap | 4.43B |
| Revenue (ttm) | 1.58B |
| Net Income (ttm) | 50.6M |
| Beta | 1.20 |
| EPS (ttm) | 0.13 |
| PE Ratio (ttm) | 89.19 |
| Forward PE | 22.18 |
| P/B (ttm) | 3.00 |
| P/S (ttm) | 2.80 |
| Earnings Date | May 9, 2024 |
| Ask | 14.78 |
| Volume | 663,428 |
| Avg. Volume (20D) | 3,690,551 |
| Open | 11.56 |
| Previous Close | 11.50 |
| Day's Range | 11.44 - 11.67 |
| 52-Week Range | 4.77 - 12.43 |
| Analyst | Buy |
| Price Target | 13 (12.07%) |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About LFST
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a multidisciplinary suite of mental health services, psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It also treats a range of mental health conditions, including ...
Financial Performance
In 2025, LifeStance Health's revenue was 1.42B, an increase of 13.85% compared to the previous year's 1.25B. Earnings were 9.66M, a decrease of -116.82%.
Financial StatementsAnalyst Forecast
According to 10 analyst ratings, the average rating for LFST stock is "Buy". The 12-month stock price forecast is 13, which is upside of 12.07% from the latest price.
Stock ForecastsEarnings Surprise
Analysts project revenue of ... Upgrade
